A detailed history of Nikko Asset Management Americas, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 199,231 shares of IONS stock, worth $7.91 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
199,231
Previous 220,261 9.55%
Holding current value
$7.91 Million
Previous $9.55 Million 0.56%
% of portfolio
0.11%
Previous 0.1%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$36.45 - $47.7 $766,543 - $1 Million
-21,030 Reduced 9.55%
199,231 $9.5 Million
Q1 2024

May 02, 2024

SELL
$42.03 - $53.55 $1.35 Million - $1.72 Million
-32,198 Reduced 12.75%
220,261 $9.55 Million
Q4 2023

Feb 08, 2024

SELL
$43.39 - $51.63 $1.74 Million - $2.07 Million
-40,014 Reduced 13.68%
252,459 $12.8 Million
Q3 2023

Nov 09, 2023

SELL
$38.5 - $47.13 $140,871 - $172,448
-3,659 Reduced 1.24%
292,473 $13.3 Million
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $46,434 - $57,932
-1,337 Reduced 0.45%
296,132 $12.2 Million
Q1 2023

May 03, 2023

SELL
$33.58 - $41.2 $1.32 Million - $1.62 Million
-39,263 Reduced 11.66%
297,469 $10.6 Million
Q4 2022

Feb 13, 2023

SELL
$37.12 - $46.52 $3.73 Million - $4.67 Million
-100,444 Reduced 22.98%
336,732 $12.7 Million
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $1.13 Million - $1.51 Million
-30,940 Reduced 6.61%
437,176 $16 Million
Q2 2022

Aug 04, 2022

SELL
$31.71 - $43.0 $4.17 Million - $5.65 Million
-131,500 Reduced 21.93%
468,116 $15.4 Million
Q1 2022

May 06, 2022

SELL
$29.88 - $37.04 $187,825 - $232,833
-6,286 Reduced 1.04%
599,616 $21.5 Million
Q4 2021

Feb 08, 2022

SELL
$25.61 - $35.1 $1.78 Million - $2.44 Million
-69,399 Reduced 10.28%
605,902 $17.9 Million
Q3 2021

Nov 09, 2021

BUY
$33.54 - $40.55 $5.6 Million - $6.77 Million
166,927 Added 32.84%
675,301 $22.6 Million
Q2 2021

Aug 09, 2021

BUY
$34.54 - $47.25 $349,475 - $478,075
10,118 Added 2.03%
508,374 $20.4 Million
Q1 2021

May 03, 2021

BUY
$42.51 - $63.78 $7.44 Million - $11.2 Million
175,088 Added 54.18%
498,256 $22.4 Million
Q4 2020

Feb 11, 2021

BUY
$45.3 - $60.27 $4.33 Million - $5.76 Million
95,501 Added 41.95%
323,168 $18.3 Million
Q3 2020

Nov 02, 2020

SELL
$47.45 - $62.95 $913,507 - $1.21 Million
-19,252 Reduced 7.8%
227,667 $10.7 Million
Q2 2020

Aug 07, 2020

SELL
$46.85 - $61.05 $6.29 Million - $8.19 Million
-134,193 Reduced 35.21%
246,919 $14.3 Million
Q1 2020

Apr 30, 2020

SELL
$41.6 - $63.4 $1.81 Million - $2.76 Million
-43,571 Reduced 10.26%
381,112 $18 Million
Q4 2019

Feb 06, 2020

BUY
$53.85 - $65.27 $3.26 Million - $3.95 Million
60,592 Added 16.64%
424,683 $25.7 Million
Q3 2019

Oct 29, 2019

BUY
$59.06 - $72.15 $3.31 Million - $4.05 Million
56,089 Added 18.21%
364,091 $21.8 Million
Q2 2019

Jul 29, 2019

BUY
$62.09 - $86.14 $7.98 Million - $11.1 Million
128,469 Added 71.56%
308,002 $19.8 Million
Q1 2019

Apr 30, 2019

BUY
$52.92 - $81.17 $9.5 Million - $14.6 Million
179,533 New
179,533 $14.6 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.